Chimerix gets FDA OK to test drug for Ebola

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Chimerix Inc. said Thursday that it has received FDA clearance to proceed with a trial examining the safety and effectiveness of its brincidofovir tablets in patients who have the virus. The company said in a statement that the drug is available for immediate use in testing.

With FDA's permission, the Durham, North Carolina, drugmaker previously made the drug available to the first Ebola patient diagnosed in the U.S., who died in Dallas last week.

The FDA does not publicly confirm when it has granted companies permission to begin testing. The agency has not approved any drugs or vaccines to treat Ebola.


Explore further

FDA lifts hold on experimental Ebola drug

© 2014 The Associated Press. All rights reserved.

Citation: Chimerix gets FDA OK to test drug for Ebola (2014, October 17) retrieved 24 November 2020 from https://medicalxpress.com/news/2014-10-chimerix-fda-drug-ebola.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments